1 / 4

Venetoclax: A BCL-2 Inhibitor Class of Drug

Venetoclax is a BCL-2 inhibitor class of drug. It is approved for treatment of CLL also named chronic lymphocytic leukemia, SLL also named small lymphocytic lymphoma, or AML (acute myeloid leukemia). Take venetoclax tablets by mouth with food as per words by your doctor. It is usually administered once daily. Swallow the tablets of venetoclax whole. Never chew, crush, or break them prior to swallowing.

amitsharma2020
Download Presentation

Venetoclax: A BCL-2 Inhibitor Class of Drug

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VENCLEXTA® (Venetoclax Tablets) chronic lymphocytic leukemia

  2. CommomVenetoclax Side Effects • low white blood cell count (neutropenia) • diarrhea. • nausea. • low blood iron (anemia) • upper respiratory tract infection. • low levels of platelets in the blood (thrombocytopenia) • fatigue. • nausea.

  3. Venclexta 100 mg is a selective small molecule BCL2 inhibitor and an oral formulation used alone or in combination with other medications to treat certain adult patients with acute myeloid leukemia (AML) that is newly diagnosed and adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This oral formulation is also being evaluated in the treatment of certain other sorts of cancer. It binds to a protein known as BCL2, which exists on some sorts of cancerous cells. Inhibiting this protein may help destroy cancerous cells and may construct them extra sensitive to anticancer medicines. This BCL2 inhibitor is also called venetoclax. Patients should avoid consuming grapefruit juice or grapefruit, Seville oranges (often used in marmalades), or starfruit during treatment with Venclexta. These products may be responsible for increasing the level of Venclexta in the blood. VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA

More Related